UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,246 | +193.2% | 160,300 | +116.6% | 0.00% | +300.0% |
| Q2 2023 | $766 | +72.5% | 74,000 | +54.2% | 0.00% | 0.0% |
| Q1 2023 | $444 | +15.6% | 48,000 | +10.9% | 0.00% | 0.0% |
| Q4 2022 | $384 | -99.9% | 43,300 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $359,000 | +0.6% | 43,100 | -1.1% | 0.00% | – |
| Q2 2022 | $357,000 | +66.0% | 43,600 | +76.5% | 0.00% | – |
| Q1 2022 | $215,000 | -63.6% | 24,700 | -24.7% | 0.00% | -100.0% |
| Q4 2020 | $591,000 | +99.7% | 32,800 | +310.0% | 0.00% | – |
| Q1 2019 | $296,000 | -62.7% | 8,000 | -52.4% | 0.00% | -100.0% |
| Q3 2018 | $793,000 | -94.1% | 16,800 | -93.8% | 0.00% | -85.7% |
| Q2 2018 | $13,531,000 | +73.8% | 272,151 | +73.7% | 0.01% | -22.2% |
| Q1 2018 | $7,786,000 | +59.6% | 156,700 | +19.5% | 0.01% | +80.0% |
| Q4 2017 | $4,878,000 | +504.5% | 131,100 | +412.1% | 0.01% | +400.0% |
| Q3 2017 | $807,000 | – | 25,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |